Old API Wind-down Ltd - Ordinary Shares ARLZQ

Can you contribute anything on this?

[InvestLargeC]

There is a rumor about a merger between ARZ and QLT:

[url=https://finance.yahoo.com/mbview/threadview/?&bn=a0f7fa04-c6a5-4779-a9f3-527775edd040&tid=1465471311257-a18f2ffa-ca6b-486f-88e4-2390933db039&tls=la%2Cd%2C1%2C3][/url]

It is worth to read all the comments.

[bunser]

Unfortunately I can't open the article to give a proper comment but hopefully it would be better than the previous merger nightmare. We have been screwed enough and it is going take time to recover from that disaster

[kuatolives]

Would be an unusual merger, given Adam's previous lauding of having a focused platform (cardio/pain) and QLTI's focus on ocular drugs of all things. That being said, if the industry is moving back towards development over acquisition, there can't be a littany of cardio/pain drugs kicking around in Phase2/3 or waiting for FDA approval that are up for sale so that business model might

[LG2264]

Now why would we want a company that has no revenues.

[kuatolives]

They have some tax credits, some fast tracked drugs in the pipeline and about 125M in cash that, right now, can be purchased for about 80-100 million. QLTI, from what I understand, has zero sales infrastructure, so even if they get their drugs approved, still have to negotiate licensing deals with someone - or as is the rumor, negotiate a buyout and transfer the assets to someone that can do

[Floridas2000]

What stage are they in for drug approval?  Is anything in final approval?  The fact that ARLZ is building up their sales team it puts us in a really good situation to sell their drugs.  But if they're years away from getting it approved what's the point.  Plus have they done any studies for potential revenue like Yosprala.

[kuatolives]

I think their big thing is something called QLT09100, a retinoid drug worth about 250 million, or so says internet chatter. Phase3 is set for 3rd quarter of this year I think. https://www.qltinc.com/development/products/QLT091001.htm ARLZ would probably just issue QLTI shareolders a bunch of ARLZ stock and absorb the assets, but who knows. Would have to wait for the terms of the deal to be

[LG2264]

From their current burn rate that 125m cash could be gone in a little over a year. We are also aware as to how long it will take to get a drug approved and to the market. It's just my humble opinion but unless we get one hell of a deal this would be another drag on earnings and share price.